Clin2
NCT06292598Possibly a fitRecruiting

Gut bacteria and sleep disorder study

Narcolepsy Type 1Bacterial Translocation

Treatments studied

Part of Brain & nervous system, Digestive system, Hormones & metabolism, Immune system & allergy clinical trials.

This study compares gut bacteria and substances from the gut in people with type 1 narcolepsy versus those without. It aims to understand how gut health might be linked to this sleep disorder.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
10 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with type 1 narcolepsy.
  • You are not currently taking narcolepsy medication at the time of first joining the study.
  • You speak and understand French.
  • You have health insurance.
  • You have not taken antibiotics in the last 3 months, and do not have a chronic digestive condition or have had weight-loss surgery in the past year.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06484348Recruiting
How food affects sleepiness in narcolepsy and hypersomnia

This study explores how what you eat affects your sleepiness and nighttime sleep quality. Researchers want to learn more about these links in people with narcolepsy type 1 or idiopathic hypersomnia.

Clermont-Ferrand
NCT07540897Recruiting· Phase 3
Testing ALKS 2680 for narcolepsy type 1

This study tests whether a new medication called ALKS 2680 can help people with narcolepsy type 1 stay more awake and alert during the day. Narcolepsy type 1 is a neurological condition where people fall asleep unexpectedly and may experience sudden muscle weakness.

Brandon, Florida
NCT07455383Recruiting· Phase 3
Testing ALKS 2680 for adults with narcolepsy type 1

This study tests a new medication, ALKS 2680, to see if it helps reduce daytime sleepiness and other symptoms in adults with narcolepsy type 1. It may offer a new treatment option for people with this condition.

Cullman, Alabama
NCT07727239Recruiting
Brain stimulation trial for people with narcolepsy type 1

This trial tests a non-invasive brain stimulation method called temporal interference to target the hypothalamus. It aims to help reduce excessive daytime sleepiness in people with narcolepsy type 1.

Xi'an, Shaanxi
NCT07633301Recruiting· Phase 2
TAK-360 Study for Adults With Narcolepsy Type 1

This study tests a new medication called TAK-360 to help adults with narcolepsy type 1 (a condition that causes extreme daytime sleepiness and sudden muscle weakness called cataplexy) feel more alert during the day. The goal is to see if this treatment is safe and effective for managing narcolepsy symptoms.

Redwood City, California
NCT07766343Not yet recruiting
Excessive sleepiness in children and teens

This study is looking at how common and how severe excessive daytime sleepiness (hypersomnia) is in children and teenagers with various sleep and developmental conditions. If your child has one of these conditions and struggles with sleepiness, they may be able to join to help doctors better understand and treat it.

Montpellier, Hérault

Hear when a new Narcolepsy Type 1 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.